Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

More documents

Recommendations

Info

19288 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 3816 ATC / . DDD MON L01XX G2 - / ( ) L01XX17 TOPOTECAN HYDROCHLORIDE 2305403 01 HYCAMTIN CAPS 0,25MG/CAP BT x 10 BLIST. SMITHKLINE BEECH 0.000947 G 2.639 2305404 01 HYCAMTIN CAPS 1MG/CAP BT x 10 BLIST. SMITHKLINE BEECH 0.000947 G 10.555 ( ) L01XX17 TOPOTECAN HYDROCHLORIDE 2305401 01 HYCAMTIN PD.INJ.SOL 4MG/VIAL BTX5VIALS SMITHKLINE BEECH 0.000618 G 32.370 2950701 02 TOPOTECAN HOSPC/S.SOL.IN 4MG/4ML 5VIALSx4ML HOSPIRA UK LIMITE 0.000618 G 32.370 2922302 02 TOPOTECAN/TEVA C/S.SOL.IN 4MG/4ML BTx5VIALSx4ML TEVA PHARMA B.V., 0.000618 G 32.370 L01XX G3 - / ( ) L01XX19 IRINOTECAN HYDROCHLORIDE TRIHYDRATE 2815401 01 BIOTECAN C/S.SOL.IN 20MG/1ML BTx1 VIAL x2ML MEDICUS A.E. 0.028833 G 1.387 2815401 02 BIOTECAN C/S.SOL.IN 20MG/1ML BTx1 VIALx5ML MEDICUS A.E. 0.028833 G 3.468 2327103 03 CAMPTO C/S.SOL.IN 20MG/ML VIAL BTx 1 VIAL x 5ML PFIZER .. 0.028833 G 3.468 2327103 04 CAMPTO C/S.SOL.IN 20MG/ML VIAL BTx 1 VIAL x 15ML PFIZER .. 0.028833 G 10.405 2327103 05 CAMPTO C/S.SOL.IN 20MG/ML VIAL BTx1 VIAL x2 ML PFIZER .. 0.028833 G 1.387 2841301 01 IRITEC C/S.SOL.IN 40MG/2ML BT x 1 VIAL VIANEX A.E. 0.028833 G 1.387 2841302 01 IRITEC C/S.SOL.IN 100MG/5ML BT x 1 VIAL VIANEX A.E. 0.028833 G 3.468 2621301 01 IRINOTECAN HYDR C/S.SOL.IN 20 MG/ML BTx1VIALx2ML HOSPIRA UK LIMITE 0.028833 G 1.387 2621301 02 IRINOTECAN HYDR C/S.SOL.IN 20 MG/ML BTx1VIALx5ML HOSPIRA UK LIMITE 0.028833 G 3.468 2802301 01 IRINOTECAN/GENE C/S.SOL.IN 20MG/ML BT x 1 VIAL x 2 ML GENERICS PHARMA 0.028833 G 1.387 2802301 04 IRINOTECAN/GENE C/S.SOL.IN 20MG/ML BT x 1 VIAL x 5 ML GENERICS PHARMA 0.028833 G 3.468 2758101 01 IRINOTECAN/TEVA C/S.SOL.IN 20MG/ML BT x 1 VIAL x 2 ML TEVA PHARMA B.V., 0.028833 G 1.387 2758101 03 IRINOTECAN/TEVA C/S.SOL.IN 20MG/ML BT x 1 VIAL x 5 ML TEVA PHARMA B.V., 0.028833 G 3.468 2834001 01 SANTACIL C/S.SOL.IN 20MG/ML BTx1 VIAL x2MLx40MG SANTA PHARMA A.E 0.028833 G 1.387 2834001 02 SANTACIL C/S.SOL.IN 20MG/ML BTx1 VIALx5MLx100MG SANTA PHARMA A.E 0.028833 G 3.468 2862201 03 MIZANTRONE C/S.SOL.IN 20MG/ML BT x 1 VIAL x 15 ML VOCATE 0.028833 G 10.405
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 19289 3816 ATC / . DDD MON 2862201 02 MIZANTRONE C/S.SOL.IN 20MG/ML BT x 1 VIAL x 5 ML VOCATE 0.028833 G 3.468 2863401 01 VINTECAN C/S.SOL.IN 20MG/ML () BTx1 (VIALx2ML) AURORA PHARMACEU0.028833 G 1.387 2863401 02 VINTECAN C/S.SOL.IN 20MG/ML () BTx1 (VIALx5ML) AURORA PHARMACEU0.028833 G 3.468 2863401 03 VINTECAN C/S.SOL.IN 20MG/ML () BTx1 (VIALx15ML) AURORA PHARMACEU0.028833 G 10.405 L01XX G4 - / ( ) L01XX23 MITOTANE 2701201 01 LYSODREN TAB 500 mg/TAB (HDPE)x100 LABORATOIRE HRA 4 G 12.500 L01XX G5 - / ( ) L01XX25 BEXAROTENE 2527201 01 TARGRETIN SOFT.CAPS 75MG/CAP 1 (HDPE)X100 EISAI LTD, UNITED K 0.82175 G 9.127 L01XX G6 - / ( ) L01XX35 ANAGRELIDE 2673601 01 XAGRID CAPS 0,5MG/CAP BTx1VIALx100 SHIRE PHARMACEU 0.002 G 25.000 L01XX G7 - / ( ) L01XX22 ALITRETINOIN 2454601 01 PANRETIN GEL 0,1 % (W/W) BTx1TUBx 60 G EISAI LTD, UNITED K 1 G 60.000 L01XX G8 - / ( ) L01XX27 ARSENIC TRIOXIDE 2521001 01 TRISENOX C/S.SOL.IN 10MG/10ML (1MG BTx10 AMPS x10ML CEPHALON EUROPE 0.0075 G 13.333
Page 1 and 2:
18959 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥ
Page 3 and 4:
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 329: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
show all

Î¥ÏÎ¿Ï ÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

Create successful ePaper yourself

Delete template?

Save as template?

Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·